Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Vascular imaging at heart of $71M fraud scheme | Planning before TAVR | FDA clears platform | Whole-body MRI provider adds CCTA
Friday, February 27, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Vascular imaging at heart of $71M fraud scheme—DOJ announces prison sentences

The years-long scheme involved sending kickbacks to physicians who ordered unnecessary transcranial doppler exams. Two conspirators have now been sentenced to prison and ordered to pay substantial fines.

READ MORE >
Medicare fraud
Share on Twitter Share on Facebook Share on Linkedin

Vascular imaging at heart of $71M fraud scheme—DOJ announces prison sentences

Share on Twitter Share on Facebook Share on Linkedin
Medicare fraud
The years-long scheme involved sending kickbacks to physicians who ordered unnecessary transcranial doppler exams. Two conspirators have now been sentenced to prison and ordered to pay substantial fines.
READ MORE >

3D software helps cardiologists plan ahead for TAVR complications

Serious complications are rare after TAVR, but they can be catastrophic or fatal when they do occur. The care team at Sentara Heart Hospital found that bringing in new 3D software made it much easier to plan ahead for such issues. 

READ MORE >
Matthew Summers, MD, FACC, program director for structural heart, Sentara Heart Hospital, Norfolk, Virginia, explains how his center used a new transcatheter aortic valve replacement (TAVR) 3D CT planning software to better identify patients who are at high risk of complications. The software also enables the heart team to test the best placement of various valves to create a procedure plan tailored for each patients unique anatomy.
Share on Twitter Share on Facebook Share on Linkedin

3D software helps cardiologists plan ahead for TAVR complications

Share on Twitter Share on Facebook Share on Linkedin
Matthew Summers, MD, FACC, program director for structural heart, Sentara Heart Hospital, Norfolk, Virginia, explains how his center used a new transcatheter aortic valve replacement (TAVR) 3D CT planning software to better identify patients who are at high risk of complications. The software also enables the heart team to test the best placement of various valves to create a procedure plan tailored for each patients unique anatomy.
Serious complications are rare after TAVR, but they can be catastrophic or fatal when they do occur. The care team at Sentara Heart Hospital found that bringing in new 3D software made it much easier to plan ahead for such issues. 
READ MORE >

FDA clears AI-powered platform that personalizes care during TAVR, cardiac pacing procedures

The newly cleared CARA System from Cara Medical was designed to help clinicians before and during a variety of cardiac procedures. It provides a personalized 3D map of the patient's cardiac conduction system and then overlays that map onto live fluoroscopic images.

READ MORE >
simulation of the conduction pathway relative to various cardiac structures.
Share on Twitter Share on Facebook Share on Linkedin

FDA clears AI-powered platform that personalizes care during TAVR, cardiac pacing procedures

Share on Twitter Share on Facebook Share on Linkedin
simulation of the conduction pathway relative to various cardiac structures.
The newly cleared CARA System from Cara Medical was designed to help clinicians before and during a variety of cardiac procedures. It provides a personalized 3D map of the patient's cardiac conduction system and then overlays that map onto live fluoroscopic images.
READ MORE >

Whole-body MRI provider starts offering AI-powered CCTA scans

Patients electing to undergo a whole-body MRI at one Florida facility are now able to undergo a CCTA exam at the same time. All results are interpreted by a cardiologist, and the patient meets with a physician for a one-on-one consultation.  

READ MORE >
Performing CT-derived fractional flow reserve (CT-FFR) before transcatheter aortic valve replacement (TAVR) improves the accuracy of coronary CT angiography (CCTA) and helps limit unneeded invasive coronary angiography (ICA), according to a new study published in JACC: Cardiovascular Interventions. Heartflow
Share on Twitter Share on Facebook Share on Linkedin

Whole-body MRI provider starts offering AI-powered CCTA scans

Share on Twitter Share on Facebook Share on Linkedin
Performing CT-derived fractional flow reserve (CT-FFR) before transcatheter aortic valve replacement (TAVR) improves the accuracy of coronary CT angiography (CCTA) and helps limit unneeded invasive coronary angiography (ICA), according to a new study published in JACC: Cardiovascular Interventions. Heartflow
Patients electing to undergo a whole-body MRI at one Florida facility are now able to undergo a CCTA exam at the same time. All results are interpreted by a cardiologist, and the patient meets with a physician for a one-on-one consultation.  
READ MORE >

Featured Articles

Excessive alcohol use increases risk of amputation in CLTI patients

Identifying patients with alcohol use disorder prior to treatment may help care teams plan ahead and anticipate potential complications.

READ MORE >
smoking and drinking
Share on Twitter Share on Facebook Share on Linkedin

Excessive alcohol use increases risk of amputation in CLTI patients

Share on Twitter Share on Facebook Share on Linkedin
smoking and drinking
Identifying patients with alcohol use disorder prior to treatment may help care teams plan ahead and anticipate potential complications.
READ MORE >

FDA shares new warning about Johnson & Johnson heart pumps after 4 injuries

This represents the latest in a series of safety concerns associated with the Impella platform. The FDA said it is still reviewing the matter and will keep the public informed as new details become available. 

READ MORE >
warning safety alert recall healthcare issue
Share on Twitter Share on Facebook Share on Linkedin

FDA shares new warning about Johnson & Johnson heart pumps after 4 injuries

Share on Twitter Share on Facebook Share on Linkedin
warning safety alert recall healthcare issue
This represents the latest in a series of safety concerns associated with the Impella platform. The FDA said it is still reviewing the matter and will keep the public informed as new details become available. 
READ MORE >

PFO closure after thromboembolism linked to strong 20-year outcomes

Recurrent strokes and TIAs were rare, though bleeding events among women did stand out as a trend to watch going forward.

READ MORE >
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
Share on Twitter Share on Facebook Share on Linkedin

PFO closure after thromboembolism linked to strong 20-year outcomes

Share on Twitter Share on Facebook Share on Linkedin
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
Recurrent strokes and TIAs were rare, though bleeding events among women did stand out as a trend to watch going forward.
READ MORE >

Women of all ages face rising risks of heart disease and stroke—but cardiologists see a path forward

Cardiovascular disease is already the No. 1 killer among women—and new projections from the American Heart Association suggest things are going to get much worse. There are certain things that clinicians and patients can do, however, to help reverse this trend and save countless lives.

READ MORE >
The National Comprehensive Cancer Network has published new patient-friendly breast cancer screening guidelines
Share on Twitter Share on Facebook Share on Linkedin

Women of all ages face rising risks of heart disease and stroke—but cardiologists see a path forward

Share on Twitter Share on Facebook Share on Linkedin
The National Comprehensive Cancer Network has published new patient-friendly breast cancer screening guidelines
Cardiovascular disease is already the No. 1 killer among women—and new projections from the American Heart Association suggest things are going to get much worse. There are certain things that clinicians and patients can do, however, to help reverse this trend and save countless lives.
READ MORE >

In Case You Missed It

FDA shares update about CGM sensor recalls—issue now linked to 860 serious injuries

Abbott first warned the public about this problem in November. Now, for the second time in less than a month, the FDA is providing additional details. 

READ MORE >
Abbott FreeStyle Libre 3 CGM
Share on Twitter Share on Facebook Share on Linkedin

FDA shares update about CGM sensor recalls—issue now linked to 860 serious injuries

Share on Twitter Share on Facebook Share on Linkedin
Abbott FreeStyle Libre 3 CGM
Abbott first warned the public about this problem in November. Now, for the second time in less than a month, the FDA is providing additional details. 
READ MORE >

New meta-analysis explores potential of endovascular treatments for long femoropopliteal lesions

Open surgical bypass is the gold standard, but endovascular therapies may provide value for high-risk patients with long femoropopliteal lesions.

READ MORE >
Peripheral artery disease (PAD) in the legs seen in a CT runoff exam. Canon Medical Systems image.
Share on Twitter Share on Facebook Share on Linkedin

New meta-analysis explores potential of endovascular treatments for long femoropopliteal lesions

Share on Twitter Share on Facebook Share on Linkedin
Peripheral artery disease (PAD) in the legs seen in a CT runoff exam. Canon Medical Systems image.
Open surgical bypass is the gold standard, but endovascular therapies may provide value for high-risk patients with long femoropopliteal lesions.
READ MORE >

SAVR linked to ‘excellent’ long-term survival for patients with bicuspid aortic valves

Survival rates are high for both men and women presenting with BAV disease, according to a new analysis of nearly 28,000 SAVR patients.

READ MORE >
According to the U.S. government, Asante Health System and one of its surgeons knowingly submitted false claims to Medicare, Medicaid and TRICARE for more than six years. Heart surgery surgeons.
Share on Twitter Share on Facebook Share on Linkedin

SAVR linked to ‘excellent’ long-term survival for patients with bicuspid aortic valves

Share on Twitter Share on Facebook Share on Linkedin
According to the U.S. government, Asante Health System and one of its surgeons knowingly submitted false claims to Medicare, Medicaid and TRICARE for more than six years. Heart surgery surgeons.
Survival rates are high for both men and women presenting with BAV disease, according to a new analysis of nearly 28,000 SAVR patients.
READ MORE >

In Other News

FDA announces recall on infusion systems after software anomaly injures 2 patients

The recall has been designated as the most serious, Class I, but the issue can be remedied with a software update. The affected devices are Ivenix Large Volume Pumps manufactured by Fresenius Kabi.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall on infusion systems after software anomaly injures 2 patients

Share on Twitter Share on Facebook Share on Linkedin
The recall has been designated as the most serious, Class I, but the issue can be remedied with a software update. The affected devices are Ivenix Large Volume Pumps manufactured by Fresenius Kabi.
READ MORE >

CMS defers $260M in Medicaid funds as part of ‘major crackdown on healthcare fraud’

The money was meant for Minnesota, where criminals were indicted for abusing the Medicaid system to run bogus daycare centers. The Centers for Medicare & Medicaid Services did not specify how the state can rectify the situation to the Trump administration’s satisfaction. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

CMS defers $260M in Medicaid funds as part of ‘major crackdown on healthcare fraud’

Share on Twitter Share on Facebook Share on Linkedin
The money was meant for Minnesota, where criminals were indicted for abusing the Medicaid system to run bogus daycare centers. The Centers for Medicare & Medicaid Services did not specify how the state can rectify the situation to the Trump administration’s satisfaction. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup